Brief: Orgenesis Announces Agreement For The Sale Of Masthercell Global
03/02/2020 12:40
Feb 3 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS ANNOUNCES AGREEMENT FOR THE SALE OF MASTHERCELL
GLOBAL, ITS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION
(CDMO) SUBSIDIARY
* ORGENESIS INC - ORGENESIS ANTICIPATES THAT IT WILL RECEIVE
PROCEEDS OF APPROXIMATELY $127 MILLION RESULTING FROM
TRANSACTION
* ORGENESIS - EXPECTS TO USE NET PROCEEDS FROM SALE OF
MASTHERCELL
TO CONTINUE TO GROW ITS POINT-OF-CARE CELL THERAPY BUSINESS
Source text for Eikon: ID:nGNX2Sjqt0
Further company coverage: ORGS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules